Displaying 11 - 16 of 16
New AI research award recipient supported by UFCW
Updated:
One of the exciting, novel aspects of LLSC’s latest blood cancer research awards is the introduction of the Artificial Intelligence (AI) Catalyst Grant, for the application of AI to blood cancer research.
Partners, Research
Accelerating and expanding blood cancer research
Updated:
The Leukemia and Lymphoma Society of Canada (LLSC) has committed nearly $5 million to blood cancer research in Canada in 2024 - with another $1.25 million from our partners!
Research
A third of blood cancer research funding to women investigators in Canada
Updated:
The Leukemia & Lymphoma Society of Canada $5 million investment includes a strong focus on an aggressive, complex form of blood cancer.
Research
Precision medicine, chemotherapy alternatives, and zebrafish genes
Updated:
Canadian researchers exploring precision medicine with immunotherapy have received a total of $600,000 from the Leukemia and Lymphoma Society of Canada (LLSC) for pediatric blood cancer research innovation.
Partners, Pediatrics, Research
Insights from BioCanRX Summit for Cancer Immunotherapy 2023
Updated:
I just got back from the 2023 BioCanRX Summit4ci that was held in Ottawa October 1-4 and I want to share a few of the amazing highlights that have come out of the conference this year.
Partners, Research, Events
LLSC partners with BioCanRx
Updated:
A new partnership between LLSC and BioCanRx will help Canadian scientists expand their ability to conduct clinical trials of CAR T therapy, an important new treatment for some blood cancers that have not responded to other treatments.
Education, Research